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Molecular Biology of Aging Review
process itself, there has been no substantial change inF. Brad Johnson, David A. Sinclair,
and Leonard Guarente* the maximum human life span.
Several avenues to studying aging have placed us onDepartment of Biology
Massachusetts Institute of Technology the threshold of understanding basic underlying mecha-
nisms. These approaches include the identification ofCambridge, Massachusetts 02139
key genes and pathways important in aging; genetic
studies of heritable diseases that cause the appearance
of premature aging in affected people; physiological ex-Introduction
periments that relate the pace of aging to caloric intake;
Is aging the final act in the script of developmental biol-
and advances in human genetics, as well as cell and
ogy? The characteristic changes that are part and parcel
molecular biology leading to an understanding of the
of aging appear similar to developmentally regulated
basis of many diseases of aging. Strikingly, single gene
programs. But why would aging mechanisms have been
mutations have been found to significantly extend the
evolutionarily selected as advantageous? Indeed, evo-
life span in C. elegans, yeast, and, most recently, Dro-
lutionary biologists might argue that aging occurs by
sophila, suggesting that aging may be relatively simple,
default due to the absence of selection in the postrepro-
at least in these organisms. Further, the limited replica-
ductive phase of life. By this view, the aging process is
tion potential of human cells in culture has been attrib-
not programmed, but, rather, the detritus of the absence
uted to a specific mechanism (i.e., the shortening of
of selection for maintenance (Medawar, 1952; Kirkwood,
telomeric ends of chromosomes). An important chal-
1977). However, it is quite reasonable that any mecha-
lenge is now to relate these recent findings to the more
nisms that sprang up to slow or regulate the pace of
complex case of human aging.
aging would be selected, because lucky individuals
In this review, we will discuss several important mo-
could potentially give rise to more progeny. Therefore,
lecular models of aging that come from current research.
it is reasonable to suppose that life span extending pro-
These are damage by reactive oxygen species (ROS)
cesses have been selected and that these can be viewed
generated by metabolism, genome instability, geneti-
as an elaboration of development itself. In principle,
cally programmed extension mechanisms, cell death,
such extension mechanisms may act to slow or forestall
and systemic aging. Questions to be posed include the
deleterious changes in an organism that progressively
following. What evidence exists for and against these
lead to death. The life span of an organism, therefore,
models? Can more than one of these models apply to
is the sum of deleterious changes and counteracting
aging of different tissues in humansÐspecifically do
repair and maintenance mechanisms that respond to
organs with continually dividing cells age by the same
the damage (Figure 1).
mechanism as organs that are postmitotic? Finally, is
A priori, one imagines such longevity mechanisms to
aging amenable to therapeutic intervention, and would
be much less complex than those regulating embryonic
such intervention be advisable?
development. The spatial and temporal constraints on
embryonic development are many, while requirements
Oxidative Damagefor longevity mechanisms might be much more specific
One theory of aging proposes that ROS which are gener-if there were a single process (or a few processes) whose
ated by metabolism cause cumulative damage over abreakdown is the limiting event in longevity (i.e., the
lifetime (Harman, 1981). Roughly two to three percentAchilles heel).
of oxygen taken up is chemically reduced by the additionAging is defined when two criteria are met. First, the
of single electrons, which are sequentially convertedprobability of death at any point in time increases with
into ROS, including the superoxide anion, hydrogen per-the age of the organism. This statistical definition applies
oxide, and the hydroxyl radical. ROS have been shownfrom yeast to mammals and reflects the progressive
to cause molecular damage relatively indiscriminatelynature of aging. Second, characteristic changes in phe-
to proteins, lipids, and nucleic acids. In addition, specificnotype occur in all individuals over time due to the lim-
damage has been observed in the mitochondrial DNA,iting processes.
which we consider below in Genome Instability.The phenotypic definition is equally general and is
What is the evidence that oxidative damage causesuseful in distinguishing the aging process itself from
aging? One category of study that is supportive of thisdiseases of aging, such as cancer and heart disease.
view involves animals transgenic for genes encodingPhenotypes of aging affect all of the individuals in a
antioxidants. Transgenic Drosophila overexpressing bothpopulation, while diseases of aging affect only a subset.
Cu/Zn SOD and catalase live 34% longer than controlsBoth impact on life span, but in different ways. For exam-
(Orr and Sohal, 1994). A more recent study shows thatple, the many advances in medicine and public health
expression of human SOD1 exclusively in Drosophilain this century have caused a large increase in the aver-
adult motor neurons leads to a 40% extension in lifeage life span of humans in developed countries. How-
span (Parkes et al., 1998). Further experiments are nec-ever, because these advances have not altered the aging
essary to clarify the nature of this primary role of motor
neurons in life span. Conversely, mice knocked out for
either GPX1 (encoding glutathione peroxidase), SOD1,* E-mail: leng@mit.edu.
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Genome Instability
The importance of specific kinds of genome instability
in aging is becoming increasingly apparent. The accu-
mulation of genomic changes (i.e., point mutations [Szi-
lard, 1959], loss of repeated DNA sequences such as
ribosomal DNA [rDNA] [Strehler, 1986], rearrangements,
and changes in chromosome number [Martin et al.,
1985]) have long been proposed as causes of aging.
The study of transgenic markers has revealed the accu-
mulation of low levels of mutations with age in mice
(Dolle et al., 1997). These changes were observed in the
liver, which has mitotic capacity, but not in the brain,
which is largely postmitotic. Age-dependent changes
have also been observed in the HPRT and HLA-A genes
of peripheral blood lymphocytes in humans (Grist et al.,
1992; King et al., 1994). However, the low frequency of
Figure 1. Life Span Is Determined by the Balance of Two Opposing these genomic changes, even in old individuals, casts
Processes doubt on their importance in aging.
Metabolism leads to the accumulation of damage (red), thus causing Ribosomal DNA
aging. Compensatory responses (green) limit or repair the damage,
A strong causal link between genome instability andthus promoting longevity.
aging has been established in the model system S. cere-
visiae. In this system, cell division is asymmetric, giving
rise to a large mother cell and a smaller daughter cell.
SOD2, or SOD3 do not display a phenotype of rapid Aging is manifest both by the limited number of cell
aging (Reaume et al., 1996; Ho et al., 1997; Melov et divisions and the changes in phenotype undergone by
al., 1998); GPX1, SOD1, and SOD3 knockout animals mother cells prior to senescence (Barton, 1950; Jazwin-
appear normal, whereas SOD2 mice die of cardiac failure ski, 1993).
at day 8. The pace of aging in mother cells is dictated by
Another possible genetic link between oxidative dam- changes occurring in the ribosomal DNA (rDNA) (Sinclair
age and aging is provided by the long-lived age-1 mutant and Guarente, 1997), which is present in 100±200 tan-
of C. elegans (Klass, 1983; Friedman and Johnson, 1988; dem copies on chromosome XII. At some point in the
Larsen et al., 1995). age-1 mutants live twice as long as middle of the life span of mother cells, a circular copy
the wild type, have increased levels of SOD and catalase of rDNA pops out of the genomic array by homologous
(Larsen, 1993; Vanfleteren and De Vreese, 1996) and recombination (Figure 2). This extrachromosomal rDNA
are more resistant to oxidative stresses (Larsen, 1993; circle (ERC) replicates via an origin present in the rDNA
Vanfleteren and De Vreese, 1996), as well as heat shock sequence during subsequent cell cycles. Importantly,
(Lithgow et al., 1994) and UV radiation (Murakami and ERCs segregate in a highly biased fashion to mother
Johnson, 1996). Similarly, the long-lived Drosophila mu- cells. Thus, daughters are born youthful and ERC free,
tant methuselah is resistant to oxidative stress and also and mothers experience an exponential buildup in ERCs
high temperature and starvation (Lin et al., 1998). Muta- leading to about 1000 copies in senescent cells. The
tion in another C. elegans gene, clk-1, slows develop- proliferation of ERCs elicits an apparent enlargement
ment and rhythmic behavior and extends life span and fragmentation of the nucleolus (Sinclair et al., 1997),
(Wong et al., 1995). Interestingly, clk-1 is a homolog of the site of rDNA transcription and ribosome assembly.
yeast CAT5 (Ewbank et al., 1997), a gene involved in The artificial creation of ERCs, by use of a site-specific
synthesis of coenzyme Q, a component of the mitochon- recombinase, at an abnormally early age shortens life
drial electron transport chain (Jonassen et al., 1998). span, indicating that ERCs are a cause of aging. We
Further, clk-1 mutants contain reduced levels of coen- imagine that the accumulated ERCs interfere with cell
zyme Q (Ewbank et al., 1997), suggesting that all the growth by titrating away critical components of the ma-
phenotypes of the clk-1 mutant, including longevity, may chinery for DNA replication and perhaps transcription.
be attributable to a slowing of metabolism. The initial clue pointing to this mechanism was the
It is interesting to note that these genetic links be- genetic control of aging by SIR4 (Kennedy et al., 1995).
tween aging and oxidative damage are found in animals This gene, along with SIR2 and SIR3, mediates genomic
in which most adult cells are postmitotic (i.e., C. elegans silencing at telomeres and the silent mating type loci
and Drosophila). Postmitotic cells may be more suscep- HML and HMR. Loss-of-function mutations in these
tible to the cumulative damage of ROS given their inabil- genes shorten life span, while a gain-of-function muta-
ity to replace themselves. In mammals, organs most tion in SIR4 extends life span. This latter allele causes
vulnerable to this mechanism are the brain, heart, and a relocalization of the SIR2/3/4p complex away from
skeletal muscle. The heart does, in fact, apparently ex- telomeres and HM loci to the nucleolus (Kennedy et al.,
perience a reduction in cell number over time, some of 1997). This mutant constitutively mimics what happens
which may be due to damage-generated apoptosis (see with aging in wild-type cells. These findings suggest
Cell Death, below). However, the link between ROS and that the relocalization of the Sir complex to the nucleolus
aging in organs consisting of dividing cells is even less may be a genetic mechanism to extend life span in wild-
type cells. A consequence of this relocalization is theclear.
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Consider normal aging as caused by a particular kind
of cumulative damage that impinges on a key cellular
process to debilitate its output. Normal longevity is pro-
moted by the activity of Gene 1, which slows the accu-
mulation of this damage. The study of a progeria due
to mutation in Gene 1 will therefore directly illuminate a
step that is the Achilles heel in normal aging. However,
a mutation in a Gene 2 encoding a component of the
process itself could, in principle, phenocopy rapid aging
by limiting the output of the process. In this case, a
study of the progeria will not immediately reveal the
limiting step in longevity (i.e., the step in which the dam-
age is produced) but may nonetheless identify a relevant
process (i.e., the step impacted by the damage).
The WRN gene has been cloned and shown to encode
a DNA helicase of the RecQ family (Yu et. al, 1996; Gray
et al., 1997; Suzuki et al., 1997). Members of this family
include SGS1 of S. cerevisiae, rqh11 of S. pombe, the
gene mutated in Bloom syndrome, BLM, and another
human homolog RECQL (Gangloff et al., 1994; Puranam
and Blackshear, 1994; Ellis et al., 1995; Stewart et al.,
1997). Studies in yeast show that SGS1 suppresses re-
combination in genomic DNA, including the rDNA (Gan-
gloff et al., 1994; Watt et al., 1996). Further, null muta-
tions in SGS1 suppress the slow growth and rDNA
hyperrecombination of top3 (topoisomerase III) mutants
(Gangloff et al., 1994) and decrease the fidelity of mitotic
and meiotic chromosome segregation (Watt et al., 1995).
Both Bloom and Werner syndromes are characterized
by chromosome instability (reviewed in Ellis, 1997). In
Figure 2. Essential Features of Aging in Saccharomyces cerevisiae the case of Bloom syndrome, there are an elevated
number of sister chromatid exchanges and varied re-Between 150±200 copies of a 9.1 kb unit encoding rRNA is located
on chromosome XII. The potentially unstable region is prone to arrangements, and patients are prone to all cancers.
homologous recombination between adjacent repeats at a DNA Werner individuals display more subtle alterations in
lesion, perhaps a stalled replication fork or DNA double-strand chromosome stability, but enhanced frequencies of de-
break. The extrachromosomal rDNA circle (ERC) replicates in ensu-
letions and rearrangements occur.ing cell cycles via the autonomously replicating sequences in the
Strikingly, deletion of the S. cerevisiae homolog,nontranscribed spacer. ERCs are preferentially held in the mother
SGS1, also causes premature aging in that organismcell, causing them to accumulate exponentially. Mother cells grow
large, and their cell cycle slows. When the ERC copy number reaches (Sinclair et al., 1997). The mutants experience the char-
between 500 and 1000, the mother cells senesce, possibly due to acteristic fragmentation of the nucleolus and accumula-
titration of essential transcription or replication factors. The SGS1 tion of ERCs in about half as many cell divisions as
and SIR genes slow the rate of ERC accumulation; SGS1 presumably
the wild type (Sinclair and Guarente, 1997) (Figure 2).limits damage or recombination, and the SIR genes act at undefined
Immunostaining reveals that both Sgs1p and the humansteps.
WRN protein are concentrated in the nucleolus in yeast
(Sinclair et al., 1997) and human cells (Gray et al., 1998;
evacuation of HM loci leading to the expression of a Marciniak et al., 1998), reinforcing the possibility that
and a mating type genes and the age-related phenotype instability of the rDNA is a critical component of aging.
of sterility (Smeal et al., 1996). In the absence of the Sgs1p helicase, ERCs form more
WRN DNA Helicase readily, probably due to elevated intrachromosomal re-
Another link between aging and the nucleolus comes combination.
from studies of the disease Werner syndrome, which is What could be the biochemical defect in cells lacking
due to loss-of-function mutations in a single gene, WRN SGS1-like DNA helicases? Recent findings suggest that
(Epstein et al., 1966; Yu et al., 1996). This disease is one a WRN-related protein is required for the formation of
of a class of human progerias, which are characterized DNA replication foci in an vitro assay programmed by
by shortened life span and the premature onset of phe- a Xenopus extract (Yan et al., 1998). A different study
notypic changes that resemble aging (Martin, 1978) (Ta- shows that the BLM helicase can unwind G quad-
ble 1). For the model systems described above, the link ruplexes in DNA (Sun et al., 1998). One possibility is that
between the genes identified and aging is clear, because these helicases remove secondary structures from the
mutations extending life span necessarily identify pro- template DNA during replication. In their absense,
cesses involved in aging. The connection between the stalled replication forks may provoke the ensuing re-
mutated genes and normal aging is less certain in the combinational events.
case of the progerias. Figure 3 presents two alternative The ERC mechanism of aging may be applicable to
mammalian organs consisting of dividing cells. Circularpossibilities for the effects of the progeroid mutations.
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clock that signals the eventual growth arrest, termed
replicative senescence, that is observed in all cultured
primary human cells. Strong support for this notion has
been recently provided by the demonstration that reacti-
vation of telomerase in certain cultured human cells can
extend their replicative life span beyond the normal limit
(Bodnar et al., 1998; Vaziri and Benchimol, 1998; but
see Kiyono et al., 1998). In addition, these apparently
immortalized cells have properties indistinguishable
from normal, untransformed cells by several phenotypic
assays (Jiang et al., 1999; Morales et al., 1999).
There are several findings that relate telomere short-
ening to aging in vivo. There appears to be a rough
correlation between telomere length and age in the hu-
man soma, for example in arteries at sites of elevated
hemodynamic stress and presumably high cell turnover
(Chang and Harley, 1995). It is possible that senescent
cells accumulate focally in vivo and because of their
altered physiology interfere with the tissues in which
they reside. For example, elevated secretion of metallo-
proteases by senescent fibroblasts could degrade der-
mal collagen (reviewed in Campisi, 1998). Support for
the importance of replicative senescence in human
aging has included (1) a weak correlation between in
vitro replicative life span and donor age (Martin et al.,
1970), (2) correlation between in vitro life span and maxi-
mum life span in interspecies comparisons (Rohme,
1981), (3) diminished in vitro replicative life span of cells
from people with premature aging syndromes (FaragherFigure 3. Models for Possible Relationships between Normal Aging
and Progeroid Disorders et al., 1993), and (4) evidence for the accumulation of
senescent cells in elderly individuals (Dimri et al., 1995).(A) Normal aging results from the accumulation of damage with
age. The damage interferes with a key cellular process critical for However, other findings and interpretations challenge
longevity, of which Gene 2 is a component. Gene 1 slows the rate the sweeping notion that telomere shortening causes
of damage accumulation, yielding a normal life span. aging. First, a recent study that used both cross-sec-
(B) A progeroid phenotype results when Gene 1 is inactivated, lead-
tional and longitudinal samples obtained from the Balti-ing to rapid accumulation of damage and premature inhibition of
more Longitudinal Study on Aging indicated that if donorthe key cell process.
health status and biopsy conditions are controlled, there(C) Inactivation of Gene 2 leads to decreased activity of the key cell
process and a premature aging phenotype. However, there is no is no significant correlation between donor age and rep-
effect on the accumulation of damage that normally limits longevity. licative life span of cultured fibroblasts (Cristofalo et
al., 1998). Second, the interspecific correlation can be
equally well explained as a correlation with animal size;
DNA has been observed in mammalian cells (reviewed larger animals generally live longer and might require
in Gaubatz, 1990). However, although there are a few cells with a greater replicative capacity to produce their
reports of changes in circular DNA with age in mammals, larger bodies (Promislow, 1993). Third, the reduced rep-
no dramatic accumulation of circular DNA with age has licative life span of some progeroid cells does not hold
been observed, and mammalian circular DNA is not for all progerias and might reflect increased cell death
known to include rDNA. The strictest analog of yeast or exit from the cell cycle for reasons unrelated to those
mother cells is probably stem cells of mitotically active of wild-type senescent cells. Indeed, WS cells exit the
organs. Although age-related changes have been noted cell cycle before their telomeres are as short as wild-
in stem cell numbers and physiology in various studies, type senescent cells (Schulz et al., 1996) and there are
it is too early to discern a pattern of changes in rDNA differences in gene expression patterns between senes-
that would be informative. cent wild-type and WS cells (Oshima et al., 1995; Toda
Telomeres et al., 1998). Fourth, the evidence for accumulation of
Telomeres, the repeated DNA sequences at the ends of senescent cells in vivo rests largely with the report of
linear chromosomes, are unable to be fully replicated cells in elderly skin that express low pH b-galactosidase,
by DNA polymerases. Thus, they will shorten with cell an activity that is observed in senescent but not early-
division unless maintained via telomerase, a ribonucleo- passage cultured cells (Dimri et al., 1995). However, the
protein enzyme that can add telomeric repeat sequences frequency of positive cells in vivo has not been deter-
to chromosome ends. Telomeres indeed shorten during mined. Moreover, there are clear differences between
replicative growth of many primary cultures of human the morphology and gene expression profiles of cultured
cells, which like most somatic tissues lack detectable senescent fibroblasts and those in the skin of elderly
telomerase activity (Harley et al., 1990). It has thus been individuals (Robbins et al., 1970; Takeda et al., 1992).
On the other hand, the finding that CD282 T cells, whichproposed that telomere shortening could be a molecular
Cell
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have shortened telomeres and decreased proliferative
capacity in culture, accumulate with age is intriguing
(Effros, 1998). More work needs to be done to examine
the frequency of senescent cells in vivo, as well as
whether sites of pathology are associated with them.
Also of note, telomeres in some mouse species tend
to be very long throughout the lifetime of the animals.
Telomerase-knockout mice have been constructed and
have not yet displayed phenotypes in the first five gen-
erations (Blasco et al., 1997). Although highly mitotic
tissues (testes, skin, and hematopoietic system) show
defects in later generations that may result from chro-
mosomal abnormalities, these changes have no clear
relationship to normal aging phenotypes (Lee et al.,
1998). It will be of interest to monitor any changes in
the early generation animals as they grow older.
Mitochondrial DNA
Genetic instability outside of the nuclear genome might
also contribute to aging (reviewed in Lee et al., 1997;
Wallace et al., 1998). The mutation rate for mitochondrial
DNA (mtDNA) is 10- to 20-fold greater than for nuclear
DNA, and it is believed that mtDNA mutations may com-
promise mitochondrial functions in different ways (Fig-
ure 4). First, defects in electron transport and oxidative
phosphorylation could lead to declines in ATP levels
and the NAD:NADH ratio. Second, defective electron
transport might increase free radical production by mi-
tochondriaÐperhaps enabling a positive feedback loop
to produce further mtDNA mutations. Third, and more
speculatively, age-associated mitochondrial defects might
induce cell death (see Cell Death, below).
Figure 4. Mitochondrial Theory of Aging
There is good evidence for a decline in the function
A single mitochondrial genome (mtDNA) incurs a loss-of-function
of the mitochondrial electron transport chain with age mutation. The mutant genome (red circle) accumulates perhaps due
in humans and other animals, particularly in postmitotic to a replicative advantage compared with wild type (green circle)
tissues (Boffoli et al., 1994). It is also clear that a variety to a point where mitochondrial and cell activities are compromised.
Three types of interference with cell function could occur. First, aof mtDNA alterations, including point mutations, dele-
decline in electron transport leads to reduced ATP synthesis. Thetions, and oxidative modifications increase with age,
electron transport complexes containing mtDNA-encoded subunitsagain preferentially in postmitotic tissues (reviewed in
are indicated by roman numerals; complexes I and IV appear most
Lee et al., 1997). However, the connection between susceptible to age-associated declines in activity (red boxes). Sec-
these two groups of findings is not as certain. Early ond, increased generation of ROS leads to damage and possibly
studies suggested that although mtDNA alterations in- further mtDNA mutations. Third, cell death is triggered by necrosis
or apoptosis, for example by release of cytochrome c. The resultingcreased with age, they were quite rare, generally less
cell dysfunction or loss could lead to a decline in tissue function.than one percent of total mtDNA. Cells contain hundreds
to thousands of mitochondrial genomes, and studies of
hereditary diseases caused by mitochondrial mutations
replace cells containing mutant mtDNA with healthyhave shown that mutated genomes must accumulate to
cells might explain a greater incidence of mtDNA muta-levels greater than 50%±80% to be apparent clinically
tions in postmitotic versus mitotic tissues. In skeletal(Sciacco et al., 1994).
muscle, fibers containing high levels of deletions areTwo recent findings suggest that age-associated mi-
deficient for cytochrome c oxidase (COX) activity, indi-tochondrial mutations might nonetheless be significant.
cating that the mutant mtDNA is interfering directly withUsing PCR amplification of the entire 16.5 kb mtDNA
electron transport (Brierley et al., 1998; Kopsidas et al.,from skeletal muscle, numerous different deletion muta-
1998). Indeed, in situ studies indicate that there aretions are found to accumulate with age, and no one type
regional differences in COX activity along fibers andof mutation predominates (Melov et al., 1995b). Thus,
these correspond to regions containing deleted mtDNAearly studies that focused on only a few types of muta-
(Muller-Hocker et al., 1993). Such COX-deficient fiberstions may have underestimated the total number. More-
increase with age, but because they represent only aover, when PCR is performed on just a few or single
few percent of total cells it is still not clear that theymuscle fibers (rather than on thousands as in earlier
contribute to the muscle weakening that occurs withstudies), deletions can account for a sizable fraction of
normal aging. Another unexplored possibility is that cer-total mtDNA, suggesting that individual mitochondria
tain mtDNA alterations could have a dominant inhibitorymay incur unique mutations, which are selectively ampli-
effect on mitochondrial function and thus might not needfied over wild-type mtDNA (Schwarze et al., 1995; Bri-
erley et al., 1998). The inability of postmitotic tissues to to accumulate to high levels to be deleterious.
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Even if mtDNA mutations accumulate and contribute
to aging, they might not be a primary cause. The C.
elegans age-1 gene encodes a presumptive cytosolic
PI-3 kinase (see below), yet mutations in this gene that
confer longevity cause mtDNA deletions to accumulate
more slowly than wild type (Melov et al., 1995a). This
finding suggests that mitochondrial deletions may occur
downstream of other aging events that are more directly
impacted by the age-1 mutation.
Genetic Programs
As stated above, the universality of aging phenotypes
within a species argues for an underlying genetic pro-
gram. The redistribution of the Sir complex from telo-
meres to the nucleolus in yeast is a specific molecular
Figure 5. Proposed Mechanism of Life Span Extension by the Dauer
example of how a genetically programmed response Genetic Pathway in Adult Caenorabditis elegans
can extend life span and also lead to a gradual change
High levels of DAF-2 ligand signal adult development. Under condi-
in phenotype. tions of starvation or overcrowding, increased activity of the DAF-16
Another example of a genetic pathway that may be forkhead transcription factor triggers dauer development. In certain
daf-2 or age-1 mutants, a partially active DAF-2/AGE-1 signal resultsrelevant in aging comes from C. elegans. After hatching,
in simultaneous expression of genes involved in adult developmentC. elegans can proceed through four larval stages di-
and dauer-specific defenses that confer longevity.rectly to adulthood, or they can enter a dormant, juvenile
stage known as dauer. Adult development can resume
if environmental conditions improve. Which develop-
1997). In age-1 and daf-2 adults, this signal is partiallymental pathway is taken depends primarily on the con-
on, allowing adult worms to enjoy an extended life span.centration of a pheromone that indicates environmental
The extension of life span may be in part due to thestresses, such as starvation, overcrowding, and high
upregulation of a wide array of cellular defenses in thetemperature. In the dauer state, worms can live up to 6
adult (as noted above), which combat oxidative andmonths, rather than the usual few weeks as adults.
other damage that occur throughout the lifetime of theMany genes have been isolated that are involved in
worm. The fact that developmental pathways can bethis developmental decision. Mutants in these so-called
manipulated to extend the life of adult worms suggestsdauer formation (daf) genes are either dauer defective
that genetic programs may regulate the pace of aging(e.g., daf-16) or dauer constitutive (e.g., daf-2 and age-1).
more generally.Strikingly, certain mutations in two of these genes, age-1
and daf-2, permit development to adulthood, but with
life span extended 2- to 4-fold (Friedman and Johnson, Cell Death
Is there a connection between cell death and aging?1988; Kenyon et al., 1993; Larsen et al., 1995; Tissen-
baum and Ruvkun, 1998). This effect has been convinc- Cells die via mechanisms that range from necrosis,
which is a relatively passive outcome of cell injury, toingly interpreted as evidence for a genetic program that
influences aging. It would appear that a particular pat- apoptosis, or programmed cell death, which is an active
and ordered process. The function of postmitotic tissuestern of gene expression and physiology of dauer larvae
has been activated in the adult organism. Mutation of might especially be compromised by cell death, be-
cause the lost cells cannot be replaced (although thedaf-16, which suppresses dauer-constitutive mutations,
also suppresses the life span extension in daf-2 and dogma that heart and brain are truly postmitotic has
recently been challenged [Eriksson et al., 1998; Kajsturaage-1 mutants, providing further evidence for this inter-
pretation (Kenyon et al., 1993; Gottlieb and Ruvkun, et al. 1998]). Apoptosis is triggered by a myriad of stimuli,
such as steroid hormones, DNA damage, withdrawal of1994).
The cloning of these three daf genes has provided growth factors, or receptor-mediated apoptosis as in
clonal deletion of immune cells. This pathway involvesinsights into the signaling pathway utilized by the worm
to regulate dauer development (Figure 5). daf-2 encodes activation of a family of proteases, termed caspases,
and nucleases, leading to the controlled degradation ofa nematode member of the family of insulin-like recep-
tors (Kimura et al., 1997), whereas age-1 encodes a cellular structures, followed by removal of the mem-
brane-bound debris by phagocytic cells. There has beenhomolog of the p110 catalytic subunit of phosphatidyl-
inositol 3-kinase (PI 3-kinase) that acts downstream of speculation that dysregulation of programmed cell death
might contribute to aging (reviewed in Warner et al.,the daf-2 receptor (Morris et al., 1996). Another gene,
daf-18, mutations in which can reverse the longevity 1997).
Both apoptotic and necrotic forms of cell death canin certain age-1 mutants, encodes a PI 3-phosphatase
homolog (Ogg and Ruvkun, 1998). be mediated by mitochondria (reviewed in Green and
Reed, 1998). Given the evidence for changes in mito-daf-16 encodes a member of the hepatocyte nuclear
factor 3/forkhead family of transcriptional activators that chondrial function during aging (see Figure 4 and above),
one wonders whether these changes contribute to cellis a target of negative regulation by the PI 3-kinase-
mediated signaling cascade (Lin et al., 1997; Ogg et al., death. Mitochondrial events that can mediate cell death
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include (1) release of mitochondrial stores of caspase et al., 1995). Further studies are necessary before the
contribution of cell death to aging can be correctlyactivators including cytochrome c, (2) disruption of the
respiratory electron transport chain, and (3) production gauged.
of ROS. Age-dependent changes in mitochondria might
trigger the above mechanisms leading to cell loss. There
Systemic Control of Agingis as yet no direct evidence for increased release of
Many of the above mechanisms of aging are cell autono-caspase activators from mitochondria with age, but the
mous (i.e., are independent of external signals). How-activity of electron transport complexes appears to de-
ever, it is possible, and, in fact, it has been suggestedcline (reviewed in Lee et al., 1997) and the rate of ROS
that systemic control of aging may occur (reviewed inproduction increases with age in many mammals (Sohal
Finch, 1990). By this view humoral factors (i.e., endocrineet al., 1994).
hormones) would coordinate the pace of aging in manyHowever, genetic data do not support a role for cell
different tissues and organs. Further, local mechanismsdeath in aging. For example, studies in C. elegans argue
like cell±cell contact or paracrine hormones could coor-against any relationship between programmed cell death
dinate aging in a proximate compartment of cells. Sys-and aging. The genetic underpinnings of both processes
temic and cell-autonomous processes are clearly nothave been extensively studied in this organism, and
mutually exclusive; cell-autonomous and systemic agingthere is no apparent overlap between the genes that
may coexist or trigger each other.affect them (reviewed in Hengartner, 1997). In addition,
A recent study in C. elegans has demonstrated thatknockout mice for the bcl2 family proteins, which nor-
the longevity enjoyed by daf-2 mutant animals is not cellmally function to inhibit caspase activation and thus
autonomous (Apfeld and Kenyon, 1998). By constructingapoptosis, do not show clear aging phenotypes, al-
mosaic animals containing a mixture of daf-2(1) andthough the bcl2 knockout does develop some pheno-
daf-2(2) cells, the authors showed that a small numbertypes that superficially resemble aging (Veis et al., 1993).
of mutant cells in any of several sublineages conferredNevertheless, there is correlative evidence in humans
a degree of longevity on the entire animal, which con-and other mammals that cell death is important in certain
tained predominantly daf-2(1) cells. This was interpretedaspects of aging. One recent study reports that more
to mean that the daf-2 gene controls the production ofthan a third of ventricular cardiac myocytes are lost
a secreted factor that dictates the pace of aging in theduring normal aging in human males, although appar-
animal. In addition, the key determinant of life span wasently not in females, and the loss of cells is accompanied
the ratio of daf-2(1) to daf-2(2) cells, and it did notby hypertrophy of the remaining cells (Olivetti et al.,
depend on the presence of mutant cells in any particular1995). A similar loss has been observed in rats; in this
lineage. This finding implies that there are not specificcase the majority of cells die via necrosis, and a substan-
adult cells that dictate the rate of aging. Rather, the leveltial number are also lost via apoptosis (Kajstura et al.,
of this secreted factor, averaged systemically, sets the1996). Neurodegenerative diseases, for example Alzhei-
life span. In Drosophila, a reduction in the activity ofmers, are clearly accompanied by extensive loss of neu-
the gene methuselah extends life span. methuselah isrons. However, the loss of neurons with normal aging
homologous to genes encoding G protein±linked trans-may not be as extensive as once thought (reviewed in
membrane receptors, raising the possibility that it mightMorrison and Hof, 1997). Recent studies indicate that
also play a role in transducing systemic aging signalsthe overall number of cortical neurons declines by only
(Lin et al., 1998).10% with aging, and although particular brain regions
Do systemic factors regulate aging in mammals? Ado show higher levels of loss, it is not clear that they are
genetic argument for a such a role might be providedresponsible for the functional changes that accompany
by the mouse gene Klotho, which encodes a humoralaging (Pakkenberg and Gundersen, 1997). It remains to
factor (Kuro-o et al., 1998). Klotho mutants have a short-be demonstrated whether genetic or pharmacological
ened life span and develop several pathologies thatinterventions that inhibit cell death can slow cardiac
might have some relationship to aging. In normal humanmyocyte or neuronal loss and have beneficial effects on
physiology, there are clear examples in which the levelsorgan function.
of endocrine factors decline with age (reviewed in Lam-On the other hand, it has been proposed that an inabil-
berts et al., 1997). Estrogen levels decline sharply atity of certain cells to undergo apoptosis might contribute
menopause, and estrogen supplementation has beento aging and diseases of aging. Cultured senescent fi-
shown to slow several degenerative processes, includ-broblasts are resistant to apoptosis, in part due to an
ing skin atrophy, osteoporosis, atherosclerosis, and cogni-inability to downregulate bcl2, and this could enable
tive decline. Moreover, a recent study suggests thatsenescent cells to accumulate in vivo with deleterious
the overall mortality rate declined in postmenopausalconsequences (Wang, 1995; see Genome Instability,
women receiving hormonal supplementaton (Grodsteinabove). There is also evidence from studies in the rat
et al., 1997). Other endocrine factors, including growthliver that apoptosis helps clear preneoplastic cells
hormone, testosterone, and DHEA-S (dehydroepian-(Grasl-Kraupp et al., 1994). An inability of apoptosis to
drosterone sulphate), decline gradually with age. Short-keep pace with increasing numbers of precancerous
term supplementation with growth hormone has beencells could thus contribute to age-associated elevations
shown to increase muscle mass, skin thickness, andin cancer rates. Interestingly, calorically restricted rats
bone density (Rudman et al., 1990).increase their hepatocyte apoptosis rates with age more
While the effects of these hormones on specific or-than rats fed ad libitum, with a consequent decline in the
incidence of hepatocellular carcinoma (Muskhelishvili gans are apparent, their relation to the aging process
Review
299
itself, if any, is not yet clear. To our knowledge, there has occurred in the past 200 years. However, slowing
the aging process may increase vitality and quality ofhas been no animal study in which hormone supplemen-
tation extended maximum life span. However, the recent life over the entire life span of individuals. In this regard,
it is noteworthy that calorically restricted rodents havefindings in C. elegans provide a basis to believe that
humoral factors may turn out to play an important role an extended life span that is relatively free of disease.
For society, the implications of slowing the aging pro-in at least some aspects of human aging.
cess are more complex. Of course, in an increasingly
overpopulated world, it would be important to offset
Perspective any significant effects on longevity with a compensatory
Recent advances in the study of aging indicate that this reduction in birth rates. In fact, in many industrialized
process is amenable to molecular analysis and may be countries, the current birth rate is sufficiently low to
relatively simple. The potential of single gene mutations afford zero or negative growth. Most importantly, if the
to greatly extend life span in model systems suggests slowing of aging is associated with improved health and
that relatively few limiting cellular or organismal pro- productivity of long-lived individuals, there may be a
cesses control the rate of aging, at least in these species. direct benefit to society. In an information-intensive era
In mammals, it is noteworthy that a simple dietary regi- when societal progress increasingly depends on the
men can extend life span. Rodents that are calorically knowledge and wisdom of individuals, this benefit should
restricted live up to twice as long as controls that are fed be at a premium.
ad libitum (reviewed in Weindruch, 1996). The restricted
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